Maelstrom Research guidelines for rigorous retrospective data harmonization by Fortier, Isabel et al.
  
 University of Groningen
Maelstrom Research guidelines for rigorous retrospective data harmonization
Fortier, Isabel; Raina, Parminder; van den Heuvel, Edwin R.; Griffith, Lauren E.; Craig,
Camille; Saliba, Matilda; Doiron, Dany; Stolk, Ronald P.; Knoppers, Bartha M.; Ferretti,
Vincent
Published in:
International Journal of Epidemiology
DOI:
10.1093/ije/dyw075
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2017
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Fortier, I., Raina, P., van den Heuvel, E. R., Griffith, L. E., Craig, C., Saliba, M., ... Burton, P. (2017).
Maelstrom Research guidelines for rigorous retrospective data harmonization. International Journal of
Epidemiology, 46(1), 103-115. https://doi.org/10.1093/ije/dyw075
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Methodology
Maelstrom Research guidelines for rigorous
retrospective data harmonization
Isabel Fortier,1* Parminder Raina,2 Edwin R Van den Heuvel,3
Lauren E Griffith,2 Camille Craig,1 Matilda Saliba,1 Dany Doiron,1
Ronald P Stolk,4 Bartha M Knoppers,5 Vincent Ferretti,6
Peter Granda7 and Paul Burton8
1Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 2McMaster
University, Department of Clinical Epidemiology and Biostatistics, Hamilton, ON, Canada, 3Eindhoven
University of Technology, Department of Mathematics and Computer Science, Eindhoven, The
Netherlands, 4University Medical Center Groningen, Department of Epidemiology, Groningen,
Groningen, The Netherlands, 5McGill University, Centre of Genomics and Policy, Montreal, Montrreal,
QC, Canada, 6Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada, 7University of
Michigan, Inter-university Consortium for Political and Social Research (ICPSR), Ann Arbor, MI, USA
and 8University of Bristol, D2K Research Group, School of Social and Community Medicine, Bristol, UK
*Corresponding author. Research Institute of McGill University Health Centre, 2155 Guy Street, office 460, Montreal, QC,
Canada. E-mail: ifortier@maelstrom-research.org
Accepted 16 March 2016
Abstract
Background: It is widely accepted and acknowledged that data harmonization is crucial:
in its absence, the co-analysis of major tranches of high quality extant data is liable to in-
efficiency or error. However, despite its widespread practice, no formalized/systematic
guidelines exist to ensure high quality retrospective data harmonization.
Methods: To better understand real-world harmonization practices and facilitate devel-
opment of formal guidelines, three interrelated initiatives were undertaken between 2006
and 2015. They included a phone survey with 34 major international research initiatives,
a series of workshops with experts, and case studies applying the proposed guidelines.
Results: A wide range of projects use retrospective harmonization to support their research
activities but even when appropriate approaches are used, the terminologies, procedures,
technologies and methods adopted vary markedly. The generic guidelines outlined in this
article delineate the essentials required and describe an interdependent step-by-step ap-
proach to harmonization: 0) define the research question, objectives and protocol; 1) as-
semble pre-existing knowledge and select studies; 2) define targeted variables and evaluate
harmonization potential; 3) process data; 4) estimate quality of the harmonized dataset(s)
generated; and 5) disseminate and preserve final harmonization products.
Conclusions: This manuscript provides guidelines aiming to encourage rigorous and ef-
fective approaches to harmonization which are comprehensively and transparently docu-
mented and straightforward to interpret and implement. This can be seen as a key step
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towards implementing guiding principles analogous to those that are well recognised as
being essential in securing the foundational underpinning of systematic reviews and the
meta-analysis of clinical trials.
Key words: Data harmonization, data integration, data processing, individual participant data, retrospective
harmonization, meta-analysis
Introduction
Collaborative research programmes co-analysing individ-
ual participant data across studies are central to contem-
porary health science. The rationales underpinning such an
approach include ensuring: sufficient statistical power;
more refined subgroup analysis; increased exposure hetero-
geneity; enhanced generalizability and a capacity to under-
take comparison, cross validation or replication across
datasets.1–3 Integrative agendas also help maximizing the
use of available data resources and increase cost-efficiency
of research programmes.1,4
Co-analysis of data across multiple studies can be
achieved in several ways, including: study-specific data
analysis (independent analysis-by-study followed by meta-
analysis of study-level estimates); pooled data analysis
(data transferred to a central server and analysed as a col-
lective whole); and federated data analysis (centralized
analysis, but the individual-level participant data remain
on local servers).5,6 However, to ensure content equiva-
lence across studies and minimize measurement/assessment
error that can cause bias or impair statistical power,7 all
such approaches require use of harmonized data.
Essentially, data harmonization achieves or improves com-
parability (inferential equivalence) of similar measures col-
lected by separate studies.8
The use of compatible protocols to prospectively collect
common measures undoubtedly facilitates harmonization.9
However, implementation of a prospective approach is not
always possible or suitable. Repeating identical protocols
is not necessarily viewed as providing evidence as strong as
that obtained by exploring the same topic but using
different designs and measures. In addition, investigators
often need, for technical or scientific reasons, to use study-
specific data collection devices. Finally, it is almost impos-
sible to foresee all future harmonization requirements
when implementing a new study. Retrospective harmon-
ization (i.e. harmonization after data collection) is thus
often the only option to permit data integration.10
Retrospective approaches have supported numerous, rela-
tively small11–15 as well as very large research pro-
grammes.16–21 For instance, international human
immunodeficiency virus (HIV) research networks22–24 that
integrate existing HIV-related data are crucial to support cur-
rent and upcoming research needs and develop appropriate
health policies in the field. However, the increasing number
of such programmes stresses an imperative to ensure quality,
reproducibility and transparency of the results produced.
In systematic reviews and meta-analyses, the validity of
a review depends on the use of a rigorous and transparent
methodology.25 Whereas traditional or narrative reviews
are useful when conducted properly, it is recognized that
they can sometimes be of poor quality, biased or lead to in-
appropriate recommendations.25 In the past decades,
guidelines for the conduct and reporting of systematic re-
views and meta-analyses have therefore been articulated
and consistently updated by consensus of experts.26–28
Such guidelines identify and provide a rationale for the
steps required to conduct a rigorous review and are con-
sidered compulsory in preparing formal review articles.
Ensuring the reproducibility and validity of harmonized
data also demands rigorous procedures, which must be
transparent if they are to be accepted as valid. However,
Key Messages
• A wide variety of initiatives use retrospective data harmonization as a keystone of their research work.
• Even when appropriate approaches are used, the terminologies, procedures, technologies and methods used vary
markedly across initiatives.
• Building on the combined findings of a phone survey, expert workshops and case studies, we have developed, and
here report, formal guidelines for retrospective harmonization comprising a series of essentials and interactive steps.
• The guidelines aim to encourage rigorous and effective approaches to harmonization, which are comprehensively
and transparently documented and straightforward to interpret and implement.
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because no systematic guidelines are currently available,
most investigators harmonizing data ‘learn the hard way’:
repeatedly encountering significant pitfalls. Reports on
retrospective harmonization procedures applied by re-
search networks have been published,13,20,29 and recently
Rolland et al. described the process used at the Fred
Hutchinson Cancer Research Center.30 Although the paper
provides a useful high -level overview of an approach com-
parable to the one we foster, it does not address the details
of the component elements we developed in the past dec-
ade to formally underpin a generic harmonization guide-
lines applicable across disciplines. Nevertheless, Rolland’s
paper concurs with us that many researchers fail to reliably
record basic information about the procedures used, deci-
sions made and challenges encountered during the harmon-
ization process and stresses the need to promote the
creation of common and rigorous approaches to harmon-
ization. Such guidance is essential for investigators new to
the field to get to know issues to be addressed, and for
groups reporting on their experience to identify the critical
information to be made available if others are to properly
estimate the quality of their work and learn from the suc-
cesses and pitfalls they encountered.
The present paper provides an overview of the profile of
key international initiatives and the approaches they use to
harmonize data. It also details the guidelines developed in
the past decade by Maelstrom Research and its partners,
through a series of iterative reviews, consensus meetings
and piloting within different harmonization programmes.
The underlying goals of the guidelines are to foster a
generic, but systematic, approach to retrospective data har-
monization, and provide methodological guidance for in-
vestigators achieving harmonization and integration of
pre-existing data. Detailed information and procedures are
provided in supplementary materials, available as
Supplementary data at IJE online.
Methods
The guidelines proposed are the results of three integrated
activities carried out from 2006 to 2015. These comprise:
a phone survey with major international initiatives to
gather a clear overview of the current retrospective har-
monization practices; formal workshops with experts to
build the guidelines and overview its iterations; and a series
of case studies to evaluate and pilot different iterations of
the guidelines.
Exploring current practices
A literature search supplemented by references from key
informants helped to identify initiatives having retrospect-
ively harmonized individual participant’s data across epi-
demiological studies (Figure 1). Research initiatives were
selected instead of specific papers because most challenges
faced and methods used ought logically to remain compar-
able across a given project, even if several publications are
generated.







databases and Google search en-
gine using a range of keywords including ‘harmonization,
pooled analysis, multiple studies consortium and meta-
analysis’. The search was supplemented by a review of the
articles cited in the selected papers and references from key
informants. Articles identified were defined as eligible if
they were published from January 2000 to March 2014
and reported results from initiatives having: achieved
retrospective harmonization and integration of individual
participant data; integrated data from at least two epi-
demiological studies; and analysed data on risk factors and
health outcomes.
A total of 1182 articles were retrieved after removal of
duplicates. Screening of titles and abstracts led to the
1897 articles—
Identified through database searching
6 articles—
Identified through contact with key informants
1182 articles — Retained after duplicates removed 
1182 articles — Screened for eligibility
153 articles — Satisfied the selection criteria
56 distinct research initiatives — Included and contacted
1029 articles — Excluded
(Non-relevant or not related to a harmonization 
project; not health-oriented research; prospective data
collection of common measures; genotype data only)
Figure 1. Flow chart describing selection of harmonization initiatives from literature search and references from key informants.
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identification of 153 articles satisfying all inclusion crite-
ria. From those articles, 56 distinct initiatives conducting
retrospective harmonization were identified and included
in the survey. For each initiative, a key respondent was
contacted by e-mail and, if not answering, re-contacted at
least once by e-mail and once by phone to ask for partici-
pation. A semi-structured questionnaire was addressed to
respondents agreeing to participate (lead investigators or a
member of the research team responsible for data harmon-
ization). The questionnaire addressed the aims, characteris-
tics and infrastructure of the project, steps and methods
applied to conduct the harmonization process, tools used
and challenges faced. Descriptive analyses were conducted
to explore the responses and compare characteristics of the
participating and non-participating initiatives.
Developing and piloting of the guidelines
A series of international workshops were organized to
gather input from experts and examine different iterations
of the guidelines. More than 100 investigators from a var-
iety of backgrounds (epidemiologists, computer scientists,
statisticians, ethicists, data librarians, etc.), research interests
(research on ageing, twins, cancer, diabetes, etc.) and over
15 countries provided input. Using an iterative review and
consensus approach, a subgroup of core investigators
brought together the results gathered through these meet-
ings, established guiding principles and developed the
Maelstrom Research guidelines. Iterative versions of the
guidelines were produced and tested within a series of har-
monization projects: Promoting Harmonisation of
Epidemiological Biobanks in Europe;31 Public Population
Project in Genomics and Society;32,33 Canadian Partnership
for Tomorrow Project;34 and Biobank Standardisation and
Harmonisation for Research Excellence in the European
Union.35 More recently, the Biobanking and Biomolecular
Resources Research Infrastructure–Large Prospective
Cohorts36 and the InterConnect project37 also applied the
guidelines proposed.
Results
Among the 56 study representatives contacted, 34 (60.7%)
responded to the survey, two (3.6%) declined participation
and 20 (35.7%) did not reply after three contacts. General
characteristics of the 34 participating initiatives are pre-
sented in Table 1. A majority of the initiatives (N ¼ 25;
73.5%) consisted of large consortia or collaborative net-
works addressing various research questions or generating
harmonized datasets to serve longer-term goals; and 19
(55.9%) harmonized data only from studies of similar de-
signs (e.g. all cohorts). Projects integrating data from
multiple countries represented 76.5% (N¼26) of the ini-
tiatives. The number of individual studies within each ini-
tiative varied from 2 to 121, half of the initiatives (N¼ 18;
52.9%) harmonizing data from more than 10 studies. As
for the total number of participants, 13 initiatives (38.2%)
integrated data from more than 100 000 individuals, 15
(44.1%) from 10 000 to 100 000 individuals and six
(17.6%) from less than 10 000 individuals. No differences
were observed when the research areas, harmonization
approaches or specific characteristics of the participating
initiatives were compared with the non-participating initia-
tives (results not shown).
Infrastructures used to host and integrate data varied
across initiatives. For the majority (N¼ 26; 76.5%), study-
specific data were sent to a central location to permit inte-
gration and analysis. However, five (14.7%) initiatives
included studies restricting data transfer, so data remained
on study-specific servers. Three (8.8%) projects included
some studies for which data were sent centrally and others
in which they were hosted locally. When data were hosted
locally, the harmonization process was generally rendered
possible by sending the studies ready-to-use scripts to gen-
erate the harmonized variables and undertake a statistical
analysis. Results generated were then combined using
meta-analysis. However, two projects used a federated ap-
proach to remotely harmonize and analyse data hosted lo-
cally. Harmonization and processing were mainly achieved
with regular statistical software (N¼ 31; 91.2%), except
for three initiatives that used specialized software de-
veloped to support harmonization. As for data processing,
algorithmic transformations (e.g. recoding of categories)
was applied by all initiatives, and statistical models (e.g. re-
gression analysis with standardized methods) were used by
more than half (N¼ 23; 67.6%).
Respondents were asked to delineate the specific pro-
cedures or steps undertaken to generate the harmonized
data requested. Sound procedures were generally
described; however, the terminologies, sequence and tech-
nical and methodological approaches to these procedures
varied considerably. Most of the procedures mentioned
were related to defining the research questions, identifying
and selecting the participating studies (generally not
through a systematic approach), identifying the targeted
variables to be generated and processing data into the
harmonized variables. These procedures were reported by
at least 75% of the respondents. On the other hand, few
reported steps related to validation of the harmonized data
(N¼ 4; 11.8%), documentation of the harmonization pro-
cess (N¼ 5; 14.7%) and dissemination of the harmonized
data outputs (N¼ 2; 5.9%).
A consensus approach was used to assemble informa-
tion about pitfalls faced during the harmonization process
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Table 1. General characteristics of the harmonization initiatives surveyed
Initiative (ref) Countries Number
of studies
Study designs Main topics
AirPROM39a International 4 Cohort; Asthma and chronic pulmonary obstructive diseases
Registry
APCSC40 International 44 Cohort Cardiovascular risk factors and stroke, coronary heart
disease and total cardiovascular diseases
BioSHaRE41 International 8 Cohort; Metabolic risk factors and obesity
Cross-sectional
CHANCES42a International 15 Cohort;
Repeated cross-
sectional
Cardiovascular diseases, diabetes mellitus, cancer, frac-
tures and cognitive impairment
CLESA11 International 6 Cohort Predictors of institutionalization, hospitalization and
mortality
CLOSER43a UK 9 Cohort;
Panel
Broad topics (interdisciplinary research across longitu-
dinal studies)
COSMIC44 International 19 Cohort Cognitive measures and dementia
DYNOPTA45 Australia 9 Cohort Cognitive measures, dementia and functional disabilities
ENGAGE46 International 36 Cohort; Cardiometabolic traits
Cross-sectional
ENRIECO20 International 19 Cohort Environmental risk factors in pregnancy and early
childhood
EPIC47 International 23 Cohort Cancer and chronic diseases
EPOSA13 International 5 Cohort Osteoarthritis
ERFC17 International 121 Cohort Cardiovascular risk factors
EURALIM21 International 7 Cross-sectional Diet and cardiovascular risk factors
GENEVA29 International 16 Observational study
not specified;




GenomEUtwin48 International 8 Registry Genetic and environmental risk factors for health and
disease
HALCyon49 UK 9 Cohort Physical capabilities
IALSA50 International 60 Cohort Cognitive and physical capabilities, health, personality
and well-being
INHANCE51 International 35 Case-control Head and neck cancer
IDEFICS12 International 7 Cohort; Childhood obesity
Cross-sectional
IPD Meta-Analysis52 Canada 3 Cohort; Cognitive measures
Cross-sectional
LASA and NLSAA53 International 2 Cohort Methodological differences in the harmonization of two
longitudinal studies
MAGGIC54 International 31 Observational study
not specified;
Survival of patients with heart failure with preserved or
reduced left ventricular ejection fraction
Clinical trial/inter-
vention trial
MeRGE55 International 30 Case-control;
Nested case-control
Restrictive diastolic filling pattern and mortality in pa-
tients post-acute myocardial infarction and patient
with chronic heart failure
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(Box 1), establish guiding principles and develop the guide-
lines. The iterative process (informed by workshops and
case studies) permitted to refine and formalize the guide-
lines. The only substantive structural change to the initial
version proposed was the addition of specific steps relating
to the validation, and dissemination and archiving of
harmonized outputs. These steps were felt essential to em-
phasize the critical nature of these particular issues.
The guidelines proposed include a series of essentials
compulsory to the success of data harmonization (Box 2)
and espouse an iterative process composed of a series of
closely related and interdependent steps. An overview of
the steps is provided below, but a comprehensive and struc-
tured description is presented as supplementary material.
The Supplementary Material (available as Supplementary
data at IJE online) lists, for each step and sub-step, The
specific: aim; rational; procedures to be applied to ensure
systematic process; issues to consider; resources that can
be useful to facilitate the process; outputs generated; and
an illustrative example. A checklist helping investigators
to oversee the harmonization process is provided in
Table 2.
Iterative steps toward data harmonization (see
also Supplementary Material
Step 0: Define the questions, objectives and protocol:
develop a protocol reflecting the potential and limitations
of the project. To ensure feasibility and reproducibility and
to guide rational decision making, the objectives and re-
search protocol must be clearly defined.
Step 1: Assemble information and select studies.
Step 1a: Document individual study designs, methods and
content: ensure appropriate knowledge and understanding of
Table 1. Continued
Initiative (ref) Countries Number
of studies
Study designs Main topics





PROG-IMT58 International 50 Cohort; clinical trial/
intervention trial
Cardiovascular events and carotid intima-media thickness
PPPSDC16 International 28 Case-control Diet and cancer
PPSRH59 International 12 Cross-sectional Self-rated health
RELATE60a International 14 Cross-sectional;
Panel
Early life conditions and older adult health
THLS61a Finland 3 Cohort; Harmonization of clinical data between three studies
Cross-sectional
TLCS and HPHS62 USA 2 Cohort Personality and health
TSC63 International 11 Cohort Hypothyroidism, coronary heart disease and mortality
risk
xTEND64 Australia 2 Cohort Health and well-being
a This information was gleaned from the initiative’s website or sources other than published articles.
AirPROM, Airway Disease Predicting Outcomes through Patient Specific Computational Modeling; APCSC, Asia Pacific Cohort Studies Collaboration;
BioSHaRE, Biobank Standardisation and Harmonisation for Research Excellence in the European Union; CHANCES, Consortium on Health and Ageing:
Network of Cohorts in Europe and in the USA; CLESA, Comparison of Longitudinal European Studies on Aging; CLOSER, Cohort & Longitudinal Studies
Enhancement Resources; COSMIC, Cohort Studies of Memory in an International Consortium; DYNOPTA, Dynamic Analyses to Optimise Ageing; ENGAGE,
European Network for Genetic and Genomic Epidemiology; ENRIECO, European initiative Environmental Health Risks in European Birth Cohorts; EPIC,
European Prospective Investigation into Cancer and Nutrition; EPOSA, European Project on Osteoarthritis; ERFC, Emerging Risk Factor Collaboration;
EURALIM, EURope ALIMentation; GENEVA, Gene Environment Association Studies; GenomEUtwin, GenomEUtwin; HALCYon, Health Ageing across the
Life Course; IALSA, Integrative Analysis of Longitudinal Studies on Aging; IDEFICS, Identification and prevention of Dietary and lifestyle-induced health Effects
In Children and infants; INHANCE, International Head and Neck Cancer Epidemiology; IPD Meta-Analysis, Harmonization of Cognitive Measures In IPD
meta-analysis; LASA and NLSAA, Longitudinal Aging Study Amsterdam and Nottingham Longitudinal Study of Activity and Ageing; MAGGIC, Meta-analysis
Global Group in Chronic Heart Failure; MeRGE, Meta-analysis Research Group in Echocardiography; MORGAM, MOnica Risk, Genetics, Archiving and
Monograph; PAGE, Population Architecture using Genetics and Epidemiology; PROG-IMT, PROGression of Carotid Intima Media Thickness study; PPPSDC,
Pooling Project of Prospective Studies of Diet and Cancer; PPSRH, Pooling Project on Self-Rated Health; RELATE, Research on Early Life and Aging Trends and
Effects; THLS, National Institute for Health and Welfare (THL) studies (FINRISK cohorts, Health 2000 cohort and Helsinki Birth Cohort Study); TLCS and
HPHLS, Terman Life Cycle Study and Hawaii Personality and Health Longitudinal Study; TSC, Thyroid Studies Collaboration; xTEND, eXtending Treatments,
Education, and Networks in Depression study.
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each study. Data comparability can be affected by heterogen-
eity of study-, population-, procedural- and data-related char-
acteristics. Information related to design, time frame and
population background will, for example, be required to
evaluate study eligibility. In addition, information related to
the specific data collected and, where relevant, standard oper-
ating procedures used will be essential to evaluate harmoniza-
tion potential and guide data processing.
Box 2. Absolute essentials required to achieve any successful harmonization project
Collaborative framework: a collaborative environment needs to be implemented to ensure the success of any harmon-
ization project. Investigators involved should be open to sharing information and knowledge, and investing time and re-
sources to ensure the successful implementation of a data-sharing infrastructure and achievement of the harmonization
process.
Expert input: adequate input and oversight by experts should be ensured. Expertise is often necessary in: the scientific
domain of interest (to ensure harmonized variables permit addressing the scientific question with minimal bias); data
harmonization methods (to support achievement of the harmonization procedures); and ethics and law (to address data
access and integration issues).
Valid data input: study-specific data should only be harmonized and integrated if the original data items collected by
each study are of acceptable quality.
Valid data output: transparency and rigour should be maintained throughout the harmonization process to ensure valid-
ity and reproducibility of the harmonization results and to guarantee quality of data output. The common variables gen-
erated necessarily need to be of acceptable quality.
Rigorous documentation: publication of results generated making use of harmonized data must provide the information
required to estimate the quality of the process and presence of potential bias. This includes a description of the: criteria
used to select studies; process achieved to select and define variables to be harmonized; procedures used to process
data; and characteristics of the study-specific and harmonized dataset(s) (e.g. attribute of the populations).
Respect for stakeholders: all study-specific as well as network-specific ethical and legal components need to be re-
spected. This includes respect of the rights, intellectual property interests and integrity of study participants, investiga-
tors and stakeholders.
Box 1. Overview of the potential pitfalls in data harmonization identified by the respondents and experts
• ensuring timely access to data;
• handling dissimilar restrictions and procedures related to individual participant data access;
• managing diversity across the rules for authorship and recognition of input from study-specific investigators;
• mobilizing sufficient time and resources to conduct the harmonization project;
• gathering information and guidance on harmonization approaches, resources and techniques;
• obtaining comprehensive and coherent information on study-specific designs, standard operating procedures, data
collection devices, data format and data content;
• understanding content and quality of study-specific data;
• defining the realistic, but scientifically acceptable, level of heterogeneity (or content equivalence) to be obtained;
• generating effective study-specific and harmonized datasets, infrastructures and computing capacities;
• processing data under a harmonized format taking into account diversity of: study designs and content, study popula-
tion, synchronicity of measures (events measured at different point in time or at different intervals when repeated)
etc;
• ensuring proper documentation of the process and decisions undertaken throughout harmonization to ensure trans-
parency and reproducibility of the harmonized datasets;
• maintaining long-term capacities supporting dissemination of the harmonized datasets to users.
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Step 1b: Select participant studies: select studies based
on explicit criteria. To ensure consistency, designs of the
studies included in a harmonization project must be similar
enough to be considered compatible.
Step 2: Define variables and evaluate harmonization
potential.
Step 2a: Select and define the core variables to be
harmonized: outline the set of outcome, exposure and con-
founding variables that will serve as reference- or target-
for the harmonization of study-specific data items and will
serve to answer the research questions addressed (i.e. the
DataSchema).38 The nature of the DataSchema variables
should reflect a satisfactory balance between targeting very
precise concepts (e.g. identical questions) that optimize
homogeneity, and acceptance of a greater degree of hetero-
geneity permitting inclusion of a larger number of studies.
Explicit delineation and documentation are essential to in-
form the scientific meaning of the DataSchema variables
Table 2. Checklist helping to review the harmonization process
Step Item Description
Step 0: define the questions and objectives 1 The research question is well defined in term of popula-
tion, exposure, comparator, outcome and timing
2 The protocol takes into account questions related to
feasibility (e.g. data access, realistic time-lines) and
provides information required to guide the harmon-
ization process
Step 1: assemble information and select studies
Step 1a: document individual study designs, methods
and content
3 Study-specific information gathered allows understand-
ing study designs, time-line, population characteris-
tics, data contents, standard operating procedures
and ethico-legal requirements to access data
Step 1b: select participant studies 4 Studies are selected based on explicit selection criteria
Step 2: define variables and evaluate harmonization
potential
Step 2a: select and define the core variables to be
harmonized (DataSchema)
5 The DataSchema variables are selected based on their
relevance in answering the research question ad-
dressed, likelihood to be generated across a number
of studies and, where relevant, input from experts
6 The DataSchema variables are clearly defined, including
their specific nature, format and acceptable level of
heterogeneity
Step 2b: determine the potential to generate the
DataSchema variables making use of study-specific
data items
7 The potential (or not) for each study to create the
DataSchema variables is assessed and documented
Step 3: process data
Step 3a: ensure access to adequate study-specific data
items and establish the overall data processing
infrastructure
8 If harmonization is possible, the study-specific data
items required to generate the DataSchema variables
are made available in a computing infrastructure
allowing data processing
9 Quality of study-specific data items is assessed and con-
sidered adequate
Step 3b: process study-specific data items under a com-
mon format to generate the harmonized dataset(s)
10 Data processing is achieved using appropriate statistical
models or processing algorithms
11 Harmonized data are generated and algorithms or mod-
els used to process data are documented
Step 4: estimate quality of the harmonized dataset(s)
generated
12 Quality and consistency of the harmonized data are as-
sessed. Where appropriate, statistical models are
applied to evaluate heterogeneity and potential bias
Step 5: disseminate and preserve final harmonization
products
13 Harmonized data are available to approved users
14 All information required to understand harmonization
procedures and to analyse the harmonized data are
accessible
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and facilitate proper decision making throughout the har-
monization process. For example, the definition of the
variable ‘participant weight’ should include its units (kg)
and a record of the decision to accept (or not) both meas-
ured and self-reported weights. In many settings it is also
crucial to define temporal proximity with other informa-
tion of interest (e.g. collections of weight and physical
activity).
Step 2b: Determine the potential to generate the core
(DataSchema) variables making use of study-specific data
items: determine whether each study can construct-or not-
each of the DataSchema variables as defined. It is neces-
sary to evaluate which studies can provide data that enable
generation of each of the DataSchema variables and to
qualitatively assess the level of similarity between the
study-specific and DataSchema variables. For example,
only studies that measure participant weights could be
viewed as being able to create the DataSchema variable
‘Measured participant weight’.
Step 3: Process data.
Step 3a: Ensure access to adequate study-specific data
items and establish the overall data processing infrastruc-
ture: ensure accessibility to, and quality of, the study-spe-
cific data items required to create the harmonized dataset.
To allow data processing, it is essential to ensure availabil-
ity and quality of all relevant study-specific data items. It is
also a prerequisite to implement a data-processing infra-
structure adapted to the context of the project and level of
access to information allowed (access to individual partici-
pants’ data, or access restricted to aggregated data or
study-level results of statistical analysis) (Table 3). The
data processing infrastructure will comprise both the
study-specific (input data) and harmonized data generated
(output data).
Step 3b: Process study-specific data under a common
format to generate the harmonized dataset(s): convert the
heterogeneous study-specific data items to DataSchema
variables. Data processing is achieved using algorithms
recoding study-specific data or statistical models based on
contemporaneous analysis (Box 3). The procedures
adopted will depend on the nature and format of the vari-
ables and on the data-processing infrastructure
implemented.
Step 4: Estimate quality of the harmonized dataset(s)
generated: understand the characteristics and utility of the
harmonized dataset(s) generated. In order to ensure statis-
tical analyses are run on data of acceptable quality, quality
control procedures must be undertaken. The procedures
should include verification of the algorithms or statistical
models applied, and generation of basic quality checks and
descriptive statistics (to evaluate consistency of the
harmonized data across studies and explore potential influ-
ence of bias). When possible, procedures should be applied
to test harmonization assumptions and assess
heterogeneity.
Step 5: Disseminate and preserve final harmonization
products: implement a sustainable infrastructure to pre-
serve and disseminate harmonized data. In order for inves-
tigators not directly involved in the harmonization process
to understand the steps and decisions taken, access to ap-
propriate documentation must also be provided. This
should include variable-specific metadata (e.g. harmoniza-
tion potential, algorithms or statistical model used to pro-
cess data) and description of the harmonization procedures
applied. Ideally, all data and metadata should be made
available in standard formats.
Discussion
Achieving retrospective harmonization is necessarily chal-
lenging. This is particularly true for multidisciplinary
initiatives like the ALPHA network (Analysing the
Longitudinal Population-based HIV/AIDS data in Africa),
including researchers from a variety of disciplines aiming
to answer a broad range of research questions. Data har-
monization is time consuming, and demands significant
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technical and scientific investments. Adding to the hurdle,
harmonization is context-specific and the process generally
needs to be repeated if new scientific questions arise.
Furthermore, investigators need to ensure that data is only
claimed to be harmonized if the process generated common
variables of acceptable quality. Fortunately, a number of
factors can facilitate the process and increase cost-effect-
iveness. For example, working within networks open to
collaboration will facilitate sharing of data, resources and
knowledge (Step 0). The identification of studies of interest
(Step 1) and evaluation of the harmonization potential
(Step 2) are facilitated by the existence of central metadata
catalogues providing comprehensive information on exist-
ing study designs and content. Catalogues can also provide
information useful to guide the development of prospective
data collections. Data processing (Step 3) and the dissemin-
ation and preservation of the harmonized datasets (Step 5)
are facilitated by usage of specialized software offering a
secure, scalable and cost-effective computing environment.
Access to comprehensive documentation about past har-
monization initiatives can inform investigators about suit-
able processing models (Step 3) and quality control
procedures (Step 4) and simplify achievement of harmon-
ization in new, but similar contexts. Finally (Step 5), pro-
viding timely, appropriately governed access to
harmonized datasets38 helps to ensure effective return on
the investments made and can act as a springboard to a
wide range of additional research activities.
It is acknowledged that harmonization is important, re-
quires thorough preparatory work, and has many elements
that must be worked through carefully and systematically.
However, many of the key steps to harmonization appear
self-evident and straightforward even if time consuming to
carry out. As a result, harmonization is often seen as a task
that can easily be undertaken even by an ‘enthusiastic ama-
teur’. This precisely reflects early perspectives on
systematic reviews, meta-analyses and clinical trials before
formal guidelines and protocols were accepted as the
norm. Unfortunately, no matter that many harmonization
efforts are of high quality, the lack of collectively agreed
terminologies and guidelines or protocols - emphasizing
both documentation and quality control - makes it almost
impossible for others to learn from those with practical ex-
perience, or even to objectively decide whether a particular
harmonization project has been done well. To descend into
cliche´: reinvention of the wheel is all too common and,
more seriously, the invention of non-functional wheels
(e.g. with a missing axle) is far from rare. Virtually nobody
with knowledge and experience in contemporary health
science would argue that it would be preferable to under-
take a clinical trial, a systematic review or a meta-analysis-
particularly a first foray into any of these activities without
following accepted guidelines. This ensures that no critical
steps are missed, everything that others might later view as
crucial information is properly documented and appropri-
ate quality assurance criteria are evaluated. It is a central
message of the current paper that harmonization should be
viewed in precisely the same way and is the reason why we
outlined these guidelines. Building robustly on the more
detailed thinking laid out in supplementary materials
(available as Supplementary data at IJE online), these
guidelines have been applied to, and developed across, a
number of harmonization initiatives that we believe have
been successful. With this as a starting point, we encourage
the scientific community, journal editors and funding agen-
cies to debate and refine these guidelines with the aim of
collectively agreeing on a generic protocol for data har-
monization. Once this has been agreed, the harmonization
procedures adopted in preparing a set of observational epi-
demiological studies for joint analysis can be held up to
scrutiny against agreed best practice. Only then will har-
monization initiatives - like systematic reviews, meta-
Box 3. Examples of data processing models
Algorithmic transformation: Continuous and categorical variables, or both, with different but combinable ranges or cate-
gories (e.g. education level, household income)
Simple calibration model: Continuous metrics with calibration model (e.g. weight in kilograms or pounds)
Standardization model: Continuous constructs measured using different scales, with no known calibration method or
bridging items (e.g. two independent memory scales)
Latent variable model: Continuous constructs measured using different scales, with no known calibration method but
with bridging items (e.g. two memory scales, with some common items)
Multiple imputation models: Continuous or categorical constructs measured using overlapping scales permitting imput-
ation of missing values (e.g. two overlapping scales measuring activities of daily living)
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analyses and clinical trials - be reliably undertaken in an ef-
fective manner, and will such initiatives be properly eval-
uated in judging grant applications, reviewing papers or
interpreting the published literature.
Supplementary data
Supplementary data are available at IJE online.
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